"Ending malaria, a disease that kills a disproportionate number of children, is going to require a high degree of ingenuity and boldness.
14322
在3期“RTS,S”试验中有两个目标年龄组：
There were 2 target age groups in the Phase 3 RTS,S trials:
14323
在6、10和14周龄时接受了疟疾疫苗以及其他儿童期常规疫苗的婴儿。
Infants who received the malaria vaccine together with other routine childhood vaccines at 6, 10 and 14 weeks of age.
14324
在5至17个月龄中间接受了第一剂疟疾疫苗的年龄较大儿童。
Older children who received their first dose of the malaria vaccinebetween 5 and 17 months of age.
14325
在较大年龄组的儿童中，得到任何剂量疫苗接种后的7天内存在发热性癫痫风险。
Among children in the older age group, there was a risk of febrile seizures within 7 days after any of the vaccine doses.
14326
在婴儿中间，这种风险仅在第四次接种后才显现出来。
Among infants, this risk was only apparent after the fourth dose.
14327
任何发热性癫痫都不会带来长期后果。
There were no long-lasting consequences due to any of the febrile seizures.
14328
在较大年龄组儿童中，与对照组相比，在接受疟疾疫苗的小组中可见脑膜炎和脑型疟病例数量上升情况。
Among children in the older age group, an increase in the number of cases of meningitis and cerebral malaria was found in the group receiving the malaria vaccine compared to the control group.
14329
这些发现与疫苗接种之间的意义尚不清楚。
The significance of these findings in relation to the vaccination is unclear.
14330
在6-12周龄的婴儿中未见脑膜炎和脑型疟增多情况。
An excess of meningitis and cerebral malaria was not seen in infants aged 6–12 weeks.